A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma-Reference-Cited by-同舟云学术

A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma

Published:2017-05-16 Issue:8 Volume:56 Page:1031-1042
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Ho Evangeline S. Q.¹,Barrett Sarah A.¹,Mullaney Laura M.¹

Affiliation:

1. Applied Radiation Therapy Trinity, Discipline of Radiation Therapy, School of Medicine, Trinity College Dublin, Dublin, Ireland

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2017.1324207

Reference57 articles.

1. MacDonald TJ, Packer RJ. Pediatric medulloblastoma clinical presentation. 2014 26 November [cited 2016 15 January]; Available from: http://reference.medscape.com/article/987886-overview - showall.

2. Medulloblastoma

3. Pediatric medulloblastoma: Toxicity of current treatment and potential role of protontherapy

4. Outcome of Medulloblastoma in Children: Long-Term Complications and Quality of Life

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Medulloblastoma in the Adolescent and Young Adult Population: A Systematic Review;Journal of Adolescent and Young Adult Oncology;2024-08-23

2. Risks of Spinal Abnormalities and Growth Impairment After Radiation to the Spine in Childhood Cancer Survivors: A PENTEC Comprehensive Review;International Journal of Radiation Oncology*Biology*Physics;2023-12

3. Cancer Control, Toxicity, and Secondary Malignancy Risks of Proton Radiation Therapy for Stage I-IIB Testicular Seminoma;Advances in Radiation Oncology;2023-09

4. The impact of radiotherapy on the hypothalamo-pituitary axis: old vs new radiotherapy techniques;Endocrine Connections;2023-07-14

5. Critical Appraisal of Proton Therapy for Patients with Central Nervous System (CNS) Malignancies;Current Treatment Options in Oncology;2023-05-22